↓ Skip to main content

Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children

Overview of attention for article published in Frontiers in Pediatrics, April 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
92 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
Published in
Frontiers in Pediatrics, April 2017
DOI 10.3389/fped.2017.00082
Pubmed ID
Authors

Sophia Tsabouri, Antigoni Mavroudi, Gavriela Feketea, George V. Guibas

Abstract

This review presents up-to-date understanding of immunotherapy in the treatment of children with allergic asthma. The principal types of allergen immunotherapy (AIT) are subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). Both of them are indicated for patients with allergic rhinitis and/or asthma, who have evidence of clinically relevant allergen-specific IgE, and significant symptoms despite reasonable avoidance measures and/or maximal medical therapy. Studies have shown a significant decrease in asthma symptom scores and in the use of rescue medication, and a preventive effect on asthma onset. Although the safety profile of SLIT appears to be better than SCIT, the results of some studies and meta-analyses suggest that the efficacy of SCIT is better and that SCIT has an earlier onset than SLIT in children with allergic asthma. Severe, not controlled asthma, and medical error were the most frequent causes of SCIT-induced adverse events.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 92 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 14%
Researcher 10 11%
Student > Master 10 11%
Other 9 10%
Student > Postgraduate 6 7%
Other 14 15%
Unknown 30 33%
Readers by discipline Count As %
Medicine and Dentistry 25 27%
Immunology and Microbiology 10 11%
Biochemistry, Genetics and Molecular Biology 10 11%
Agricultural and Biological Sciences 5 5%
Nursing and Health Professions 3 3%
Other 6 7%
Unknown 33 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 May 2017.
All research outputs
#14,931,166
of 22,965,074 outputs
Outputs from Frontiers in Pediatrics
#2,289
of 6,025 outputs
Outputs of similar age
#183,898
of 309,877 outputs
Outputs of similar age from Frontiers in Pediatrics
#49
of 80 outputs
Altmetric has tracked 22,965,074 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,025 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 309,877 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.